Case example in action
The integration of phenylephrine and ketorolac injection 1%/0.3% (Omidria, Omeros Corp.) into cataract procedures performed by the Island Eye Surgicenter, Westbury, NY, is one example of this process in action.
The dedicated eye surgery center is a new 27,000-square-foot, state-of-the-art facility with about 18,000 ophthalmic procedures performed each year. The facility has six operating rooms; two femtosecond laser devices (Catalys Precision Laser Systems, Johnson & Johnson Vision); 15 preoperative stretcher locations; 12 postoperative positions, and an 80-seat waiting room, plus ample equipment and supply storage areas.
The 45-plus surgeons who operate at the center come from practices throughout Long Island and the Tri-State area, attracted by the facility itself and a highly trained staff. Many of these surgeons participate as principal investigators in research studies of new technology, and the facility is often among the first ASCs in the country to offer the most advanced surgical or therapeutic tools to surgeons and patients.
The center also hosts physicians visiting from other parts of the country and from around the world, who come to learn from surgeons’ experiences with new interventions.
The dissemination of new technologies or techniques is more complicated than simply changing the protocol in a single practice, because the center is a free-standing facility utilized by surgeons from many independent practices. It is in everyone’s interests to ensure the diffusion and uptake of new technology that improves post-surgical outcomes and patient satisfaction. That has been the mission of the owner-physicians from day one.